Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of 5.64x is 71% above its 5-year average of 3.29x, around the middle of its 5-year range (-0.08x–8.18x).
14.15% below its 12-month average of 6.57x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2027 (2026-07-31): 7.83x.
INTEREST COVERAGE RATIO
5.64x
INTEREST COVERAGE RATIO AVG TTM
6.57x
INTEREST COVERAGE RATIO AVG 3Y
4.72x
INTEREST COVERAGE RATIO AVG 5Y
3.29x
INTEREST COVERAGE RATIO AVG 10Y
2.65x
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-14.15%
CURRENT VS 3Y AVG
+19.51%
CURRENT VS 5Y AVG
+71.19%
CURRENT VS 10Y AVG
+112.95%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.42x
median of 436 covered companies
CURRENT VS SECTOR MEDIAN
+204.06%
vs the sector median at left
HealthEquity, Inc.
Market Cap
$7.66B
Interest Coverage Ratio
5.64x
TTM Avg
6.57x
3Y Avg
4.72x
5Y Avg
3.29x
Market Cap
$7.70B
Interest Coverage Ratio
-5.89x
TTM Avg
8.36x
3Y Avg
8.36x
5Y Avg
8.36x
Market Cap
$7.92B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$7.37B
Interest Coverage Ratio
-4.22x
TTM Avg
7.50x
3Y Avg
4.09x
5Y Avg
4.09x
Market Cap
$8.00B
Interest Coverage Ratio
0.79x
TTM Avg
0.79x
3Y Avg
0.79x
5Y Avg
1.52x
Market Cap
$7.13B
Interest Coverage Ratio
20.69x
TTM Avg
19.66x
3Y Avg
19.10x
5Y Avg
16.50x
Market Cap
$8.44B
Interest Coverage Ratio
-22.52x
TTM Avg
2.41x
3Y Avg
2.41x
5Y Avg
2.41x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| HealthEquity, Inc. (HQY) | $7.66B | 5.64x | 6.57x | 4.72x | 3.29x |
| Cytokinetics, Incorporated (CYTK)vs › | $7.70B | -5.89x | 8.36x | 8.36x | 8.36x |
| Hinge Health, Inc. (HNGE)vs › | $7.55B | N/A | N/A | N/A | N/A |
| Praxis Precision Medicines, Inc. (PRAX)vs › | $7.92B | N/A | N/A | N/A | N/A |
| Ionis Pharmaceuticals, Inc. (IONS)vs › | $7.37B | -4.22x | 7.50x | 4.09x | 4.09x |
| Caris Life Sciences, Inc. (CAI)vs › | $8.00B | 0.79x | 0.79x | 0.79x | 1.52x |
| Alkermes plc (ALKS)vs › | $7.13B | 20.69x | 19.66x | 19.10x | 16.50x |
| Oscar Health, Inc. (OSCR)vs › | $8.44B | -22.52x | 2.41x | 2.41x | 2.41x |
| Immunovant, Inc. (IMVT)vs › | $6.75B | N/A | N/A | N/A | N/A |
| Chemed Corporation (CHE)vs › | $6.68B | 193.28x | 199.58x | 145.92x | 155.47x |
Interest Coverage
5.6x
Debt/Equity
0.49
Current Ratio
2.99
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-07-31 | 7.83x |
| 2026-04-30 | 8.18x |
| 2026-01-31 | 5.08x |
| 2025-10-31 | 5.68x |
| 2025-07-31 | 6.08x |
| 2025-04-30 | 5.68x |
| 2025-01-31 | 4.69x |
| 2024-10-31 | 2.98x |
| 2024-07-31 | 3.94x |
| 2024-04-30 | 3.71x |
| 2024-01-31 | 3.02x |
| 2023-10-31 | 2.48x |
| 2023-07-31 | 2.02x |
| 2023-04-30 | 1.78x |
| 2023-01-31 | 1.28x |
| 2022-10-31 | 0.99x |
| 2022-07-31 | 0.46x |
| 2022-04-30 | 0.19x |
| 2022-01-31 | -0.08x |
| 2021-10-31 | 1.08x |
| 2021-07-31 | 2.14x |
| 2021-04-30 | 1.95x |
| 2021-01-31 | 1.93x |
| 2020-10-31 | 2.83x |
| 2020-07-31 | 2.18x |
| 2020-04-30 | 2.27x |
| 2020-01-31 | 1.82x |
| 2019-10-31 | 2.70x |
| 2013-07-31 | 361.30x |
| 2013-04-30 | 292.60x |
